Item 7.01. Regulation FD Disclosure
On January 4, 2023, 180 Life Sciences Corp. (the "Company") issued a press
release announcing publication of a review on the biological basis of
Dupuytren's disease. A copy of the press release is furnished hereto
as Exhibit 99.1, and incorporated by reference into this Item 7.01.
The information in Item 7.01 of this Form 8-K and Exhibit 99.1 attached hereto,
shall not be deemed "filed" for purposes of Section 18 of the Securities
Exchange Act of 1934, as amended (the "Exchange Act") or otherwise subject to
the liabilities of that section, nor shall it be deemed incorporated by
reference in any filing under the Securities Act of 1933, as amended, or the
Exchange Act, except as expressly set forth by specific reference in such a
filing. The furnishing of this Report is not intended to constitute a
determination by the Company that the information is material or that the
dissemination of the information is required by Regulation FD.
The press release furnished as Exhibit 99.1 to this Current Report on Form 8-K,
contains forward-looking statements within the safe harbor provisions of the
federal securities laws, including under The Private Securities Litigation
Reform Act of 1995, and, as such, may involve known and unknown risks,
uncertainties and assumptions. These forward-looking statements relate to the
Company's current expectations and are subject to limitations and qualifications
set forth in the press release, as well as in the Company's other filings with
the Securities and Exchange Commission, including, without limitation, that
actual events and/or results may differ materially from those projected in such
forward-looking statements. These statements also involve known and unknown
risks, which may cause the results of the Company, its divisions and concepts to
be materially different than those expressed or implied in such statements.
Accordingly, readers should not place undue reliance on any forward-looking
statements. Forward-looking statements may include comments as to the Company's
beliefs and expectations as to future financial performance, events and trends
affecting its business and are necessarily subject to uncertainties, many of
which are outside the Company's control. More information on potential factors
that could affect the Company's financial results is included from time to time
in the "Forward-Looking Statements," "Risk Factors" and "Management's Discussion
and Analysis of Financial Condition and Results of Operations" sections of the
Company's periodic and current filings with the SEC, including the Form 10-Qs
and Form 10-Ks, filed with the SEC and available at www.sec.gov. Forward-looking
statements speak only as of the date they are made. The Company undertakes no
obligation to publicly update or revise any forward-looking statements, whether
as a result of new information, future events or otherwise that occur after that
date, except as otherwise provided by law.
Item 9.01. Financial Statements and Exhibits
(d) Exhibits.
Exhibit No. Description
99.1* Press Release dated January 4, 2023
104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
* Furnished herewith.
1
© Edgar Online, source Glimpses